AA received research grants and lecture or advisory board fees from MSD, AstraZeneca, Novartis, Boehringer Ingelheim, Sanofi, Mediolanum, Janssen, Novo Nordisk, Lilly, Servier and Takeda
Acknowledgements We acknowledge that English language were edited by professor Jiang-Zhang from Guangxi Medical University, who is jointly awarded PhD degree by University of Florence, University of Pisa and University of Siena in Italy, and professor Jun Wu from City of Hope National Medical Center of The United States of America
Objetivos teraputicos: La indicacin clnica influye significativamente en la dosis objetivo
The manufacturer of tirzepatide is also running a large study called the SURPASS-CVOT trial
10.1186/s13098-018-0392-8 Diabetol
Breaks between cycles are common to allow the body to balance itself naturally